1.河北省沧州中西医结合医院骨科院区脊柱脊髓外三科,沧州 061000
2.河北省沧州中西医结合医院内分泌 糖尿病一科,沧州 061000
3.河北省沧州中西医结合医院骨科院区内分泌糖尿病科,沧州 061000
刘德峰,男,41岁,硕士,副主任医师。研究方向:中医及中西医结合骨外科学。
扫 描 看 全 文
刘德峰,刘爱茹,高娟娟,等.健脾益气活血汤联合阿仑膦酸钠治疗糖尿病合并骨质疏松症的疗效观察[J].北京中医药,2023,42(10):1069-1075.
LIU De-feng,LIU Ai-ru,GAO Juan-juan,et al.Observation on the curative effect of Jianpi Yiqi Huoxue Decoction combined with alendronate sodium in the treatment of diabetes mellitus complicated with osteoporosis[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(10):1069-1075.
刘德峰,刘爱茹,高娟娟,等.健脾益气活血汤联合阿仑膦酸钠治疗糖尿病合并骨质疏松症的疗效观察[J].北京中医药,2023,42(10):1069-1075. DOI: 10.16025/j.1674-1307.2023.10.005.
LIU De-feng,LIU Ai-ru,GAO Juan-juan,et al.Observation on the curative effect of Jianpi Yiqi Huoxue Decoction combined with alendronate sodium in the treatment of diabetes mellitus complicated with osteoporosis[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(10):1069-1075. DOI: 10.16025/j.1674-1307.2023.10.005.
目的,2,观察健脾益气活血汤联合阿仑膦酸钠治疗糖尿病合并骨质疏松症(DOP)的临床疗效。,方法,2,选取2021年6月—2022年6月河北省沧州中西医结合医院内分泌糖尿病科门诊收治的DOP患者106例,采用随机数字表法分为2组。对照组53例给予阿仑膦酸钠片治疗,观察组53例给予健脾益气活血汤内服+阿仑膦酸钠片治疗。6个月后观察2组临床疗效;比较治疗前后2组糖代谢指标[空腹血糖(FPG)、糖化血红蛋白(HbA,1,c)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)],骨密度,中医证候积分,血液流变学指标[血浆黏度(PV)、全血高切黏度(HBV)、全血低切黏度(LBV)、红细胞聚集指数(EAI)],以及血清骨代谢生化指标[碱性磷酸酶(ALP)、I型原胶原N-端前肽(P1NP)、Ⅰ型胶原交联C-末端肽β-降解产物(β-CTX)],胰岛素样生长因子1(IGF-1),趋化素(Chemerin)水平;统计2组不良反应发生情况。,结果,2,观察组总有效率88.68%,高于对照组的73.58%(,P,<,0.05)。治疗后,2组血清FPG、HbA,1,c、FINS水平及HOMA-IR均较治疗前降低(,P,<,0.05);观察组血清FINS水平及HOMA-IR均低于对照组(,P,<,0.05)。治疗后,2组L,1~4,骨密度均较治疗前增加(,P,<,0.05),中医证候积分较治疗前降低(,P,<,0.05);观察组L,1~4,骨密度、中医证候积分与对照组比较,差异有统计学意义(,P,<,0.05)。治疗后,观察组股骨颈、全髋骨密度均高于治疗前(,P,<,0.05),对照组与治疗前比较,差异无统计学意义(,P,>,0.05);2组PV、HBV、LBV、EAI均较治疗前降低(,P,<,0.05),且观察组PV、HBV、LBV、EAI低于对照组(,P,<,0.05);2组血清ALP、P1NP、β-CTX水平均较治疗前降低(,P,<,0.05),且观察组血清ALP、P1NP、β-CTX水平低于对照组(,P,<,0.05)。治疗后,2组血清IGF-1水平较治疗前升高(,P,<,0.05),血清Chemerin水平较治疗前降低(,P,<,0.05);且观察组血清IGF-1水平高于对照组(,P,<,0.05),血清Chemerin水平低于对照组(,P,<,0.05)。治疗过程中,对照组发生恶心1例、头痛1例,观察组发生恶心2例、腹痛1例,2组不良反应发生率差异无统计学意义(,P,>,0.05)。,结论,2,健脾益气活血汤联合阿仑膦酸钠治疗DOP的整体疗效确切,其作用可能与该中西医结合方案能有效改善患者胰岛素抵抗、纠正血液流变学异常以及调节血清骨代谢生化指标、IGF-1、Chemerin水平有关。
Objective,2,To observe the clinical effect of Jianpi Yiqi Huoxue Decoction(invigorating spleen qi and activating blood)combined with alendronate sodium on diabetes mellitus complicated with osteoporosis(DOP).,Methods,2,A total of 106 DOP patients admitted to the Department of Endocrinology and Diabetes in Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine from June 2021 to June 2022 were selected and divided into 2 groups according to random number table method. The control group was treated with alendronate sodium tablets. On this basis, the observation group was treated with Jianpi Yiqi Huoxui Decoction. The clinical effect of 2 groups was observed after 6 months of treatment,including Glucose metabolism indexes [fasting blood glucose(FPG), HbA,1,c,fasting insulin(FINS), insulin resistance index(HOMA-IR)], bone density, TCM syndrome score, hemorheology indexes [plasma viscosity(PV), whole blood high tangential viscosity(HBV), whole blood low tangential viscosity(LBV), red blood cell aggregation index(EAI)] of the two groups, serum biochemical indexes of bone metabolism, such as alkaline phosphatase(ALP), type I procollagen N-terminal peptide(P1NP), type I collagen cross-linked C-terminal peptide β-degradation product(β-CTX), insulin-like growth factor 1(IGF-1)and Chemerin levels were were compared before and after treatment. The adverse reactions of the 2 groups were analyzed.,Results,2,The total effective rate of observation group(88.68%)was higher than that of control group(73.58%)(,P,<,0.05). After treatment, serum levels of FPG, HbA,1,c, FINS and HOMA-IR in 2 groups were lower than that before treatment(,P,<,0.05). Serum FINS level and HOMA-IR in observation group were lower than those in control group(,P,<,0.05). Bone mineral density (BMD) from L1 to L4 in both groups was increased compared with that before treatment(,P,<,0.05), and TCM syndrome score was decreased compared with that before treatment(,P,<,0.05) and The difference was statistically significant(,P,<,0.05). After the treatment,bone mineral density of femoral neck and total hip in the observation group was higher than that before treatment(,P,<,0.05), but there was no statistical significance in BMD of femoral neck and hip before and after treatment in the control group(,P,>,0.05). PV, HBV, LBV and EAI in the 2 groups were lower than before treatment(,P,<,0.05), and PV, HBV, LBV and EAI in the observation group were lower than those in the control group(,P,<,0.05). Serum ALP, P1NP and β-CTX levels in 2 groups were lower than those before treatment(,P,<,0.05), and serum ALP, P1NP and β-CTX levels in observation group were lower than those in control group(,P,<,0.05). The serum IGF-1 level in 2 groups was higher than before treatment(,P,<,0.05), and the serum Chemerin level was lower than before treatment(,P,<,0.05). The serum IGF-1 level in observation group was higher than that in control group(,P,<,0.05), and the serum Chemerin level was lower than that in control group(,P,<,0.05). In control group, nausea and headache occurred in 1 case each. Nausea occurred in 2 cases and abdominal pain occurred in 1 case in the observation group. There was no significant difference in the incidence of adverse reactions between the two groups(,P,>,0.05).,Conclusion,2,The overall curative effect of Jianpi Yiqi Huoxue Decoction combined with alendronate sodium in the treatment of DOP is exact, and its effect may be related to the effective improvement of insulin resistance, correction of hemorheological abnormalities and regulation of serum biochemical indexes of bone metabolism, IGF-1 and Chemerin levels of the integrated traditional Chinese and western medicine program.
糖尿病骨质疏松症健脾益气活血汤阿仑膦酸钠
Diabetes mellitusosteoporosisJianpi Yi Huoxue Tang(invigorating spleen qi and activating blood decoction)alendronate sodium
LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020,369:m997.
卢艳慧, 李春霖. 老年2型糖尿病合并骨质疏松的临床进展[J]. 中华糖尿病杂志, 2020, 12(6):353-356.
DE ARAUJO IM, MOREIRA MLM, DE PAULA FJA. Diabetes and bone[J]. Arch Endocrinol Metab, 2022,66(5):633-641.
XIONG Z, YI P, TANG X, et al. Meta-analysis of the efficacy and safety of alendronate combined with atorvastatin in the treatment of osteoporosis in diabetes mellitus[J]. Biomed Res Int, 2022,2022:6747469.
ZHAO Y, QIU J, CHEN T, et al. The efficacy and safety of traditional Chinese medicine's tonifying-kidney, strengthening-spleen, and invigorating-blood circulation (Bushen-Jianpi-Huoxue) principle for type 2 diabetes mellitus with osteoporosis: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2021,100(12):e25197.
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409.
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 原发性骨质疏松症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(4):304-315.
郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社, 2002: 356-360.
SUN L, YU H, TIAN D, et al. Risk factors of elderly type 2 diabetes mellitus complicated with osteoporosis and effects of vitamin K1 on bone mineral density and insulin resistance[J]. Am J Life Sci, 2019,7(1):12-16.
SHEU A, GREENFIELD JR, WHITE CP, et al. Contributors to impaired bone health in type 2 diabetes[J]. Trends Endocrinol Metab, 2022,34(1):34-48.
VIGGERS R, AL-MASHHADI Z, STARUP-LINDE J, et al. The efficacy of alendronate versus denosumab on major osteoporotic fracture risk in elderly patients with diabetes mellitus: a danish retrospective cohort study[J]. Front Endocrinol (Lausanne), 2022,12:826997.
杨娜, 肖颖, 刘静云. 茯苓多糖调控SIRT1/FOXO3a通路对妊娠糖尿病大鼠胰岛素抵抗的影响[J]. 中国优生与遗传杂志, 2022, 30(8):1371-1375.
韩林静, 吴克亮, 王宏波, 等. 基于网络药理学探讨黄芪治疗骨质疏松症的分子机制[J]. 中国骨质疏松杂志, 2020, 26(8):1119-1125.
白璧辉, 谢兴文, 李鼎鹏, 等. 杜仲及其有效成分防治骨质疏松症研究进展[J]. 辽宁中医药大学学报, 2019, 21(1):126-129.
LOYOLA-LEYVA A, LOYOLA-RODRIGUEZ JP, BARQUERA S, et al. Differences in erythrocytes size and shape in prediabetes and diabetes assessed by two microscopy techniques and its association with dietary patterns. Pilot study[J]. Microsc Res Tech, 2022,85(12):3726-3735.
FARBER PL, DIAS A, FREITAS T, et al. Evaluation of hemorheological parameters as biomarkers of calcium metabolism and insulin resistance in postmenopausal women[J]. Clin Hemorheol Microcirc, 2021,77(4):395-410.
LORENTZON M, BRANCO J, BRANDI ML, et al. Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis[J]. Adv Ther, 2019,36(10):2811-2824.
ZHANG WB, YE K, BARZILAI N, et al. The antagonistic pleiotropy of insulin-like growth factor 1[J]. Aging Cell, 2021,20(9):e13443.
施良, 张浩, 李林, 等. 2型糖尿病患者血清chemerin水平与骨密度相关性研究[J]. 中国骨质疏松杂志, 2016, 22(1):67-71.
熊伟, 赵亮. 盐炙杜仲对维甲酸诱导的骨质疏松大鼠骨生长因子及骨代谢的影响[J]. 亚太传统医药, 2020, 16(12):23-25.
刘倩, 范颖, 刘丽, 等. 基于脂肪组织细胞因子探讨黄芪葛根配伍对糖尿病大鼠降糖降脂的作用机制[J]. 中药药理与临床, 2019, 35(4):20-23.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构